Literature DB >> 7506564

Expression and dynamic modulation of the human granulocyte colony-stimulating factor receptor in immature and differentiated myeloid cells.

A Khwaja1, J Carver, H M Jones, D Paterson, D C Linch.   

Abstract

In this study we have examined the expression and modulation of the human granulocyte colony-stimulating factor (G-CSF) receptor (R) in immature and differentiated myeloid cells using a 125I labelled human G-CSF analogue (TG50). Equilibrium binding data revealed a single affinity class of receptor on all cell types expressing G-CSFR (KD 235-606 pM) with neutrophils expressing 2883 +/- 672 Rs/cell. Rapid internalization of surface receptor-bound ligand at 37 degrees C was detected in both immature cells (U937) and neutrophils with > 70% of specifically bound ligand internalized within 5 min. Concentration-response data showed that the level of occupancy of neutrophil G-CSFRs by ligand at 37 degrees C was approximately 5-fold greater than predicted by equilibrium binding data and correlated closely with concentration-response data for biological activity. Re-expression of G-CSFRs following down-regulation by internalization was not detected. Down-regulation of the neutrophil G-CSFR by several agents including granulocyte-macrophage colony-stimulating factor (GM-CSF), tumour necrosis factor (TNF), lipopolysaccharide (LPS), f-met-leu-phe (fMLP), phorbol ester (TPA) and C5a was observed at 37 degrees C but not at 4 degrees C. In contrast, G-CSFRs on immature myeloid cells were significantly down-regulated by TPA only. Differentiation of myeloid leukaemic cell line HL-60 with DMSO, a frequently used model of granulocytic differentiation, was associated with a significant reduction in G-CSFR expression (11 +/- 5% of control) whereas treatment with retinoic acid led to increased G-CSFR expression (161 +/- 3%).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506564     DOI: 10.1111/j.1365-2141.1993.tb03164.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

1.  A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation.

Authors:  Ivar Østby; Leiv S Rusten; Gunnar Kvalheim; Per Grøttum
Journal:  J Math Biol       Date:  2003-04-23       Impact factor: 2.259

2.  Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.

Authors:  Manfred Weiss; Sami Voglic; Britt Harms-Schirra; Ingrid Lorenz; Britta Lasch; Kristoffel Dumon; Wilhelm Gross-Weege; Elisabeth Marion Schneider
Journal:  Intensive Care Med       Date:  2003-04-08       Impact factor: 17.440

3.  Cellular level models as tools for cytokine design.

Authors:  Mala L Radhakrishnan; Bruce Tidor
Journal:  Biotechnol Prog       Date:  2010 Jul-Aug

Review 4.  Pharmacokinetics and pharmacodynamics of pegfilgrastim.

Authors:  Bing-Bing Yang; Anna Kido
Journal:  Clin Pharmacokinet       Date:  2011-05       Impact factor: 6.447

5.  Predictors of response of patients with solid tumors to granulocyte colony-stimulating factor.

Authors:  Hiroaki Ohnaka; Hitoshi Tsukamoto; Toshiaki Nakamura; Ryoichi Yano; Kyohei Watanabe; Toshiaki Igarashi; Nobuyuki Goto; Mikio Masada
Journal:  Int J Clin Pharm       Date:  2012-09-26

6.  Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulating factor derivative Maxy-G34 and pegfilgrastim in rats.

Authors:  M Scholz; C Engel; D Apt; S L Sankar; E Goldstein; M Loeffler
Journal:  Cell Prolif       Date:  2009-09-24       Impact factor: 6.831

7.  Neutrophil elastase downmodulates native G-CSFR expression and granulocyte-macrophage colony formation.

Authors:  Melissa G Piper; Pam R Massullo; Megan Loveland; Lawrence J Druhan; Tamila L Kindwall-Keller; Jing Ai; Alexander Copelan; Belinda R Avalos
Journal:  J Inflamm (Lond)       Date:  2010-01-21       Impact factor: 4.981

8.  Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, and lowest effective dose.

Authors:  Spyros A Papiris; Panagiotis Tsirigotis; Likurgos Kolilekas; Georgia Papadaki; Andriana I Papaioannou; Christina Triantafillidou; Anastasia Papaporfyriou; Anna Karakatsani; Konstantinos Kagouridis; Matthias Griese; Effrosyni D Manali
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

9.  A pharmacokinetic model of filgrastim and pegfilgrastim application in normal mice and those with cyclophosphamide-induced granulocytopaenia.

Authors:  M Scholz; M Ackermann; C Engel; F Emmrich; M Loeffler; M Kamprad
Journal:  Cell Prolif       Date:  2009-08-17       Impact factor: 6.831

10.  Effectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model.

Authors:  Markus Scholz; Manuela Ackermann; Frank Emmrich; Markus Loeffler; Manja Kamprad
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.